Fulgent Genetics, Inc.

FLGTReported to SECin USCIK 0001674930Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 11. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 11
Form 4 lines at Fulgent Genetics, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Xie JianPresident and COOOpen-market sell$41,8092,127 sharesSep 3, 2026Xie JianPresident and COO$41,809Sell · Sep 3Open-market sell2,127Sep 3, 2026
Gao HanlinChief Scientific OfficerOpen-market sell$32,8851,673 sharesSep 3, 2026Gao HanlinChief Scientific Officer$32,885Sell · Sep 3Open-market sell1,673Sep 3, 2026
Hsieh MingChief Executive OfficerAdministrative$86,0394,392 sharesSep 3, 2026Hsieh MingChief Executive Officer$86,039Admin · Sep 3Administrative4,392Sep 3, 2026
Kim PaulCFO and TreasurerAdministrative$40,8842,087 sharesSep 3, 2026Kim PaulCFO and Treasurer$40,884Admin · Sep 3Administrative2,087Sep 3, 2026
Xie JianPresident and COOOpen-market sell$23,7471,193 sharesAug 28, 2026Xie JianPresident and COO$23,747Sell · Aug 28Open-market sell1,193Aug 28, 2026